Study S000374

Clinical Evaluation of Psoriatic Arthritis Treated With Liraglutide. The PLAQUE Study: Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02472717
Acronym: PLAQUE
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: TRIPLE
Status: WITHDRAWN
Enrollment: 0
Start: 2015-05
Primary completion: 2016-10
Lead sponsor: University Health Network, Toronto
Conditions: Psoriatic Arthritis; Psoriasis; Impaired Glucose Tolerance; Type 2 Diabetes
Interventions: DRUG:liraglutide; OTHER:Placebo
Results posted: FALSE

Registered primary outcomes

The change in the proportion of patients achieving an ACR 20% improvement response in patients with psoriatic arthritis receiving liraglutide for 12 weeks compared to placebo [Baseline to 12 weeks, liraglutide compared to placebo]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.